Interestingly, we found that the expression of ANXA2 also increased after CAMKK2 overexpression, and we also found that bufalin-treated ICC cells overexpressing CAMKK2 with a dose-dependent increase (Fig. 6A). Here, ANXA2 is linked to intrahepatic cholangiocarcinoma.